Quantcast

Latest Nootropics Stories

2014-02-25 08:32:17

TORONTO, Feb. 25, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that the Company's President and Chief Executive Officer, David Lickrish, will present at the 34(th) Annual Cowen and Company Health Care Conference at the Boston Marriott Copley Place in Boston, MA. Highland's presentation is scheduled for Monday, March 3, 2014 at 11:00am EST. A live webcast of the presentation can be accessed by visiting...

2014-02-21 23:24:20

Alpha Brain reviews have been popping up all over the Internet and GentlemensUniversity.com reveals the truth about this brain supplement that claims to help in nerve growth for better brain development. Houston, TX (PRWEB) February 21, 2014 Onnit Labs Alpha Brain, a brain supplement that promises to provide its users various benefits, the most important of which are razor-sharp focus, increased mental drive, and vivid and lucid dreams has caught the attention of...

2014-02-13 08:30:34

DUBLIN, February 13, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Graham Hetherington, Chief Financial Officer (CFO), has notified the Board of Directors of his decision to step down. The Board has agreed that Graham will step down from Shire's Board of Directors on March 1, 2014. Shire's Senior Vice President and Group Financial Controller, James Bowling, will be appointed as interim Shire CFO with effect from that date. Shire will start immediately...

2014-02-11 23:29:05

MedicationDiscountCard.com makes treating ADHD more affordable. San Antonio, TX (PRWEB) February 11, 2014 The Diagnostic and Statistical Manual (DSM5) says that about 5% of children in the United States have attention-deficit hyperactivity disorder, or ADHD. Boys are diagnosed more often than girls, and numbers vary by state, with some states reaching as high as 18% of children diagnosed with ADHD. When children aren't properly medicated, the extra care they require puts a huge...

2014-02-06 23:29:13

Alcohol & Drug Rehab Chicago helps people get relief from their alcohol and drug addiction problems. Call (773) 313-3019 for a free appointment. Chicago, IL (PRWEB) February 06, 2014 A Chicago alcohol and drug rehab center is announcing that it has launched an effort toward reducing prescription drug abuse through Drug Addiction Treatment Centers. According to statistics from the National Institute on Drug Abuse, 7.6 percent of 12th-graders used Adderall, 7.6 percent used Vicodin, 5.3...

2014-02-06 16:28:08

DUBLIN, February 6, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces top-line results from two pivotal Phase 3 investigational studies evaluating the efficacy and safety of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) versus placebo as an adjunctive treatment for major depressive disorder (MDD) in adults who inadequately responded to antidepressant monotherapy with a SSRI or SNRI. Vyvanse did not meet the primary efficacy endpoint versus placebo for...

2014-01-17 04:20:47

DUBLIN, January 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, today announced that it has entered into a definitive agreement pursuant to which it has sold its DERMAGRAFT assets to Organogenesis Inc. DERMAGRAFT is a living skin substitute indicated for use in the treatment of full-thickness diabetic foot ulcers and is approved for use in the US and Canada. Going forward Organogenesis will assume all financial and...

2014-01-14 12:26:31

DUBLIN, January 14, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) Dr. Flemming Ornskov, Chief Executive Officer of Shire, will address investors today, Tuesday, January 14, 2014, at the JP Morgan Healthcare Conference in San Francisco. In his address he will confirm that Shire finished 2013 strongly, having successfully performed a strategy shift and introduced greater operational discipline. Shire now expects to deliver Non GAAP EPS growth at the upper end of...

FDA Warning Issued On ADHD Drug Due To Painful Priapism
2013-12-17 15:58:44

Brett Smith for redOrbit.com - Your Universe Online A type of stimulant used to treat attention deficit disorders can lead to the development of long-lasting and sometimes painful erections, the Food and Drug Administration (FDA) said in a written warning released on Tuesday. The condition, referred to as priapism, was linked in an FDA review to males between 8 to 33 years of age who took drugs containing methylphenidate, the active ingredient in Ritalin and Concerta. “Patients who...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related